74 related articles for article (PubMed ID: 22075553)
1. Implantation of biomaterial as an efficient method to harvest mesenchymal stem cells.
Wu X; Liu X; Wang S
Exp Biol Med (Maywood); 2011 Dec; 236(12):1477-84. PubMed ID: 22075553
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of the biological characteristics of mesenchymal stem cells from bone marrow and peripheral blood of rats.
Fu WL; Zhang JY; Fu X; Duan XN; Leung KK; Jia ZQ; Wang WP; Zhou CY; Yu JK
Tissue Eng Part A; 2012 Sep; 18(17-18):1793-803. PubMed ID: 22721583
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.
Lu LL; Liu YJ; Yang SG; Zhao QJ; Wang X; Gong W; Han ZB; Xu ZS; Lu YX; Liu D; Chen ZZ; Han ZC
Haematologica; 2006 Aug; 91(8):1017-26. PubMed ID: 16870554
[TBL] [Abstract][Full Text] [Related]
4. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow-derived mesenchymal stromal cells from patients with end-stage renal disease are suitable for autologous therapy.
Reinders ME; Roemeling-van Rhijn M; Khairoun M; Lievers E; de Vries DK; Schaapherder AF; Wong SW; Zwaginga JJ; Duijs JM; van Zonneveld AJ; Hoogduijn MJ; Fibbe WE; de Fijter JW; van Kooten C; Rabelink TJ; Roelofs H
Cytotherapy; 2013 Jun; 15(6):663-72. PubMed ID: 23419679
[TBL] [Abstract][Full Text] [Related]
6. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
[TBL] [Abstract][Full Text] [Related]
7. Comparison of in vitro hepatogenic differentiation potential between various placenta-derived stem cells and other adult stem cells as an alternative source of functional hepatocytes.
Lee HJ; Jung J; Cho KJ; Lee CK; Hwang SG; Kim GJ
Differentiation; 2012 Oct; 84(3):223-31. PubMed ID: 22885322
[TBL] [Abstract][Full Text] [Related]
8. Growth kinetics and self-renewal of human mesenchymal stem cells derived from bone marrow of children with oncohematological diseases during expansion in vitro.
Isaikina Y; Kustanovich A; Svirnovski A
Exp Oncol; 2006 Jun; 28(2):146-51. PubMed ID: 16837907
[TBL] [Abstract][Full Text] [Related]
9. [Transplantation of mesenchymal derived stem cells followed by G-CSF injection can reconstitute hematopoiesis of lethally irradiated BALB/c mice].
Hu Y; Ma L; Ma GJ; Jiang XY; Zhao CH
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Feb; 24(1):20-4. PubMed ID: 12905834
[TBL] [Abstract][Full Text] [Related]
10. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
Wang X; Cheng Q; Li L; Wang J; Xia L; Xu X; Sun Z
Exp Cell Res; 2012 Feb; 318(3):196-206. PubMed ID: 22100911
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different culture conditions for human mesenchymal stromal cells for clinical stem cell therapy.
Haack-Sorensen M; Friis T; Bindslev L; Mortensen S; Johnsen HE; Kastrup J
Scand J Clin Lab Invest; 2008; 68(3):192-203. PubMed ID: 17852829
[TBL] [Abstract][Full Text] [Related]
12. Quantifying mesenchymal stem cells in the mononuclear cell fraction of bone marrow samples obtained for cell therapy.
Alvarez-Viejo M; Menendez-Menendez Y; Blanco-Gelaz MA; Ferrero-Gutierrez A; Fernandez-Rodriguez MA; Gala J; Otero-Hernandez J
Transplant Proc; 2013; 45(1):434-9. PubMed ID: 23375334
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of TGF-β/Smad signaling by BAMBI blocks differentiation of human mesenchymal stem cells to carcinoma-associated fibroblasts and abolishes their protumor effects.
Shangguan L; Ti X; Krause U; Hai B; Zhao Y; Yang Z; Liu F
Stem Cells; 2012 Dec; 30(12):2810-9. PubMed ID: 23034983
[TBL] [Abstract][Full Text] [Related]
14. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
Isaikina Y; Shman T
Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
[TBL] [Abstract][Full Text] [Related]
15. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease.
Heeschen C; Lehmann R; Honold J; Assmus B; Aicher A; Walter DH; Martin H; Zeiher AM; Dimmeler S
Circulation; 2004 Apr; 109(13):1615-22. PubMed ID: 15037527
[TBL] [Abstract][Full Text] [Related]
16. Comparative cellular and molecular analyses of pooled bone marrow multipotent mesenchymal stromal cells during continuous passaging and after successive cryopreservation.
Mamidi MK; Nathan KG; Singh G; Thrichelvam ST; Mohd Yusof NA; Fakharuzi NA; Zakaria Z; Bhonde R; Das AK; Majumdar AS
J Cell Biochem; 2012 Oct; 113(10):3153-64. PubMed ID: 22615164
[TBL] [Abstract][Full Text] [Related]
17. Adipose tissue-derived stem cells for cell therapy of airway allergic diseases in mouse.
Jang HJ; Cho KS; Park HY; Roh HJ
Acta Histochem; 2011 Sep; 113(5):501-7. PubMed ID: 20598357
[TBL] [Abstract][Full Text] [Related]
18. The additive effect of mesenchymal stem cells and bone morphogenetic protein 2 on γ-irradiated bone marrow in mice.
Liu S; Hu P; Hou Y; Li P; Li X; Tian Q
Cell Biochem Biophys; 2011 Dec; 61(3):539-50. PubMed ID: 21755409
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti-apoptosis capabilities.
Choudhery MS; Khan M; Mahmood R; Mehmood A; Khan SN; Riazuddin S
Cell Biol Int; 2012 Aug; 36(8):747-53. PubMed ID: 22352320
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous- and allogeneic-stimulated lymphocytes in vitro.
Bocelli-Tyndall C; Bracci L; Spagnoli G; Braccini A; Bouchenaki M; Ceredig R; Pistoia V; Martin I; Tyndall A
Rheumatology (Oxford); 2007 Mar; 46(3):403-8. PubMed ID: 16920750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
